Concepedia

Lorenza Landi

LL

Statistics

Publications

44

Citations

3.4K

H-Index

29

Active since

2009

Affiliations

Istituti di Ricovero e Cura a Carattere Scientifico(Current)

Azienda Unità Sanitaria Locale Della Romagna

Azienda Ospedaliera San Gerardo

Fondazione IRCCS Istituto Nazionale dei Tumori

Azienda Ospedaliero-Universitaria Careggi

Lorenza Landi is an author at Istituti di Ricovero e Cura a Carattere Scientifico specializing in medicine, oncology, and molecular oncology.

ORCID

Publications per year

2009–2025

44

Publications

44

PD-1 and PD-L1 expression in molecularly selected non-small-cell lung cancer patients

Armida D’Incecco, Mariacarla Andreozzi, Vienna Ludovini et al. · British Journal of Cancer · 2014 · 605 citations · Full text

, , +17

Crizotinib in <i>MET</i> -Deregulated or <i>ROS1</i> -Rearranged Pretreated Non–Small Cell Lung Cancer (METROS): A Phase II, Prospective, Multicenter, Two-Arms Trial

Lorenza Landi, Rita Chiari, Marcello Tiseo et al. · Clinical Cancer Research · 2019 · 186 citations · Full text

, , +16

Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLC

Marcelo V. Negrão, Haniel A. Araújo, Giuseppe Lamberti et al. · Cancer Discovery · 2023 · 181 citations · Full text

, , +17

Bone metastases and immunotherapy in patients with advanced non-small-cell lung cancer

Lorenza Landi, Federica D’Incà, Alain Gelibter et al. · Journal for ImmunoTherapy of Cancer · 2019 · 171 citations · Full text

, , +12

HER2 gene copy number status may influence clinical efficacy to anti-EGFR monoclonal antibodies in metastatic colorectal cancer patients

V. Martin, Lorenza Landi, Francesca Molinari et al. · British Journal of Cancer · 2013 · 160 citations · Full text

, , +17

1–5 of 44